UEG Journal

Episode 2: UEG Journal June spotlight

Episode 1: UEG Journal May spotlight

GI pearls from the latest literature published in UEGJ

Transcriptomic dive into microscopic colitis

Ahsen Ustaoglu interviews Dr Celia Escudero-Hernandez on their transcriptomic study delving into the pathogenesis of lymphocytic colitis, where they identified two subtypes of lymphocytic colitis: channelopathic and inflammatory lymphocytic colitis, which could pave the way for novel biomarkers and therapeutic avenues.

Non-invasive biomarkers for NAFLD: Liver special

In this episode, Ahsen Ustaoglu interviews Prof Vincent Wong on their comprehensive review of non-invasive biomarkers and imaging tools for non-alcoholic fatty liver disease which has a rapidly rising incidence worldwide.

Association between pancreatic adenocarcinoma and organochlorine pesticides

Ahsen Ustaoglu interviews Dr Mathias Brugel on their targeted screening analysis of pancreatic adenocarcinoma risk with organoclorine pesticides from the PESTIPAC study

Therapeutic sequencing in IBD: Determining the optimal position of vedolizumab in Crohn's Disease

In this episode, Dr. Tarik Kani interviews Dr Christian Agboton from USA about the optimal position of Vedolizumab in long-term Crohn's Disease

UEGJ Best Paper Award: Work productivity in DGBIs

Join Ahsen Ustaoglu and H. Tarik Kani as they interview Dr Asa Frandemark on their study investigating work impairment in disorders of gut-brain interactions which assessed retrospective data from the Rome Foundation Global Epidemiology Study

A new bowel cleansing system: A multicenter prospective study

In this episode, Dr. Tarik Kani interviews Dr Milou van Riswijk from The Netherlands about a new bowel cleansing system which was designed to overcome an important issue for endoscopists and patients.

Gallstone Disease Relapse: Insights from the RELAPSTONE Study

In this episode, Ahsen Ustaoglu interviews Dr Raul Velamazan to discuss their findings from the multicentre RELAPSTONE study on recurrence patterns and risk factors for relapse after first admission of patients with symptomatic gallstone disease

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.

Dr. Tarik Kani interviews Dr Alberto Zanetto from Italy, on their study which they were created a new model to predict acute-on-chronic liver failure in decompensated cirrhosis.

Effect of miR-10b in regulating gut barrier dysfunction in diabetes and GI dysmotility

Dr Ahsen Ustaoglu interviews Dr Rajan Singh and Dr Hannah Zogg from the University of Nevada, USA, on their study which investigated the role of microRNA 10b-5p in regulating gut barrier function in an in vivo model of diabetes and gastrointestinal dysmotility, important mechanistic work in the field of Neurogastroenterology.

Interactive Insights With Your UEG Podcast Hosts: UEGW Special

In this December special episode, your UEG Journal podcast hosts H. Tarik Kani and Ahsen Ustaoglu are joined by UEG Talks podcast hosts Egle Dieninyte and Pradeep Mundre in hosting very special guests at UEG Week 2023 in Copenhagen. You can expect to hear important insights from Dr Enrique de Madaria and UEG Journal Editor-in-Chief Prof Joost Drenth, as well as Young GIs.

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Dr. H. Tarik Kani talks to Dr. Anouk Wijnands (Netherlands) about her multicenter cohort study that investigated the relationship between smoking and colorectal neoplasia in patients with Inflammatory Bowel Disease with a 10-year follow-up.

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program

Dr Ahsen Ustaoglu interviews Dr Iris Levink on her study investigating the additive value of CA19.9 monitoring in a pancreatic cyst surveillance program, part of the PACYFIC-trial (www.pacyfic.net).

Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: STARDUST trial

Dr. H. Tarik Kani talks to Dr. Axel Dignass (Germany) about his recent publication about the impact of Ustekinumab on health-related quality of life in moderate-to-severe Crohn’s disease which was an open-label, multicenter, randomized study evaluated the quality of life prospectively in Crohn’s patients who treated with Ustekinumab.

Towards a robust and compact deep learning system for primary detection of early Barrett’s neoplasia

Ahsen Ustaoglu talks to Dr Martjin Jong (the Netherlands) on their recent paper developing an image-based deep learning system for primary detection of early Barrett's neoplasia

Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor

Dr. H. Tarik Kani talks to Dr Gabriele Dragoni (Italy) about his recent paper about the comparison of two strategies for the management of postoperative recurrence in Crohn’s disease which was a multicenter study evaluated the two strategies which are using in postoperative follow-up.

Fluorescence-Guided Endoscopy Targets for Detecting Colorectal Polyps with HGD and T1 Cancer

Ahsen Ustaoglu talks to Dr Nik Dekkers and Dr Jurjen Boonstra (the Netherlands) on their recent study investigating suitable imaging biomarker targets to differentiate high-grade dysplasia (HGD) and T1 colorectal cancer (T1CRC) from low-grade dysplasia (LGD) in colorectal polyps.

Transmural remission improves clinical outcomes up to 5 years in Crohn's disease

H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.

Treat-to-target and sequencing therapies in Crohn’s disease

Ahsen Ustaoglu talks to Dr Nathaniel Cohen (Israel) about his recent paper on treat to target and sequencing therapies in Crohn’s disease, part of the Special issue: Changing Paradigms in Management of Inflammatory Bowel Disease.

Are we providing the correct pancreatic enzyme treatment in chronic pancreatitis?

Iago Rodríguez-Lago talks to Dr Erchinger (Norway) about his recent paper about pancreatic enzyme treatment, where he and all co-authors have evaluated the adherence to guidelines in a European cross‐sectional observational study.

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Iago Rodríguez-Lago talks to Dr Savarino (Italy) about his recent paper about functional bowel disorders with diarrhoea, where he and all co-authors have performed a Delphi consensus with experts from 10 European countries. This multinational group of European expertssummarize the current state of consensus on the definition, diagnosis, and managementof these disorders.

UEG Journal Best Paper Award 2022 - Combining biologics and small molecules in IBD

Katarzyna Pawlak talks to Dr Goessens (Belgium) about his recent paper on the efficacy and safety of combining biologic agents and small molecules in IBD, recognized with the UEG Journal 2022 Best Paper Award.

Autoimmune pancreatitis and inflammatory bowel disease

Iago Rodríguez-Lago talks to Dr Vujasinovic (Sweden) about the relationship between autoimmune pancreatitis and inflammatory bowel disease, that has been explored by his research group through an analysis of the experience from two referral centers and a systematic review of the literature.

The present and future of Neurogastroenterology

Katarzyna Pawlak talks to Dr Melchior (France) and Dr Keszthelyi (The Netherlands) about how to the interest in Neurogastroenterology nowadays, as this is an area with a great future.

Fecal microbiota transplantation and the impact of COVID-19

Iago Rodríguez-Lago talks to Prof Siew Ng (Hong Kong, China) about her research about the presence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation.

Risk factors, epidemiology and prognosis of cholangiocarcinoma

Iago Rodríguez-Lago talks to Nina Barner-Rasmussen (Helsinki, Finland) about her research on the prevalence of cholangiocarcinoma in Finland.

Angiotensin receptor blockers: its influence in patients on a gluten-free diet

Iago Rodríguez-Lago talks to Neil O'Morain (Galway, Ireland) about his research about the effect of angiotensin receptor blockers in patients on a gluten-free diet.

UEG Journal Best Paper 2021 - Rotating or single course antibiotics for small intestinal bacterial overgrowth?

Katarzyna Pawlak and Iago Rodríguez-Lago talk to Nicolas Richard and Chloé Melchior about their research about the best treatment strategy for small intestinal bacterial overgrowth, awarded as the best paper in UEG Journal published during 2021.

Plasma procalcitonin as an early predictor of liver injury in acetaminophen poisoning

Katarzyna Pawlak, social media editor, talks to Alexandre Nuzzo about his recent findings from a prospective study about the role of serum procalcitonin in patients with acetaminophen poisoning.